Insider trading

Period: 120 months Stock: IONS Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

238 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

238 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

238 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

238 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
238 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
238 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

238 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
6 Feb 2023
Monia Brett P Chief Executive Officer
Sold, plan not stated
$1.00M 24,651 at 40.69
14.5%
6 Feb 2023
HOUGEN ELIZABETH L EVP, Finance & CFO
Sold, plan not stated
$84.39K 2,079 at 40.59
2.7%
6 Feb 2023
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold, plan not stated
$78.46K 1,920 at 40.86
4.4%
6 Feb 2023
Geary Richard S EVP, Chief Development Officer
Sold, plan not stated
$78.07K 1,920 at 40.66
2.6%
6 Feb 2023
Swayze Eric EVP Research
Sold, plan not stated
$74.03K 1,815 at 40.79
5.4%
6 Feb 2023
BENNETT C FRANK EVP, Chief Scientific Officer
Sold, plan not stated
$73.56K 1,813 at 40.57
2.5%
6 Feb 2023
Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc
Sold, plan not stated
$59.00K 1,451 at 40.66
6.4%
6 Feb 2023
Schneider Eugene EVP, Chf Clinical Develop Ofcr
Sold, plan not stated
$57.46K 1,413 at 40.67
5.4%
31 Jan 2023
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold, plan not stated
$178.70K 4,500 at 39.71
10.2%
30 Jan 2023
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold, plan not stated
$177.37K 4,500 at 39.42
9.2%
18 Jan 2023
Monia Brett P Chief Executive Officer
Sold, plan not stated
$989.95K 25,066 at 39.49
17.2%
18 Jan 2023
HOUGEN ELIZABETH L EVP, Finance & CFO
Sold, plan not stated
$328.72K 8,280 at 39.70
10.1%
18 Jan 2023
Geary Richard S EVP, Chief Development Officer
Sold, plan not stated
$311.53K 7,873 at 39.57
10.0%
18 Jan 2023
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold, plan not stated
$309.48K 7,836 at 39.49
13.9%
18 Jan 2023
BENNETT C FRANK EVP, Chief Scientific Officer
Sold, plan not stated
$271.36K 6,978 at 38.89
9.3%
18 Jan 2023
Swayze Eric EVP Research
Sold, plan not stated
$223.80K 5,631 at 39.74
15.8%
18 Jan 2023
Schneider Eugene EVP, Chf Clinical Develop Ofcr
Sold, plan not stated
$188.05K 4,752 at 39.57
17.5%
18 Jan 2023
Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc
Sold, plan not stated
$148.22K 3,748 at 39.55
16.8%
18 Jan 2023
Baroldi Joseph EVP, Chief Business Officer · indirect
Sold, plan not stated
$14.92K 375 at 39.79
30.6%
17 Jan 2023
KLEIN JOSEPH III Director
Sold, plan not stated
$80.00K 2,000 at 40.00
10.6%
8 Sep 2022
Swayze Eric EVP Research
Sold, plan not stated
$20.49K 460 at 44.55
2.3%
5 Aug 2022
Swayze Eric EVP Research
Sold, plan not stated
$45.20 1 at 45.20
0.0%
15 Jul 2022
KLEIN JOSEPH III Director
Sold, plan not stated 2×
$50.98K 1,333 at 38.24
6.6%
21 Apr 2022
Swayze Eric EVP Research
Sold, plan not stated
$16.69K 378 at 44.15
1.8%
12 Apr 2022
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold, plan not stated
$272.06K 6,792 at 40.06
16.4%
1 Apr 2022
Monia Brett P Chief Executive Officer
Sold, plan not stated
$13.31K 355 at 37.49
0.4%
15 Jul 2021
KLEIN JOSEPH III Director
Sold, plan not stated
$152.99K 4,334 at 35.30
19.3%
23 Jun 2021
Sold, plan not stated
$566.10K 15,000 at 37.74
12.9%
15 Jun 2021
MUTO FREDERICK T Director
Sold, plan not stated 3×
$549.50K 15,000 at 36.63
32.1%
1 Mar 2021
Monia Brett P Chief Executive Officer
Sold, plan not stated
$12.81K 236 at 54.28
0.5%
26 Jan 2021
CROOKE STANLEY T Exec Chairman of the Board
Sold, plan not stated
$1.81M 28,333 at 63.74
93.3%
Sold half or more
25 Jan 2021
O'NEIL PATRICK R. EVP & General Counsel
Sold, plan not stated
$338.07K 5,324 at 63.50
16.7%
22 Jan 2021
CROOKE STANLEY T Exec Chairman of the Board · indirect
Sold, plan not stated
$2.47M 40,000 at 61.68
7.5%
21 Jan 2021
CROOKE STANLEY T Exec Chairman of the Board · indirect
Sold, plan not stated 2×
$2.14M 35,000 at 61.20
6.1%
13 Jan 2021
Geary Richard S EVP, Chief Development Offc
Sold, plan not stated
$8.39K 141 at 59.50
0.5%
5 Jan 2021
Swayze Eric EVP, Research
Sold, plan not stated
$10.92K 195 at 55.99
3.7%
23 Dec 2020
PARSHALL B LYNNE Director
Sold, plan not stated
$600.00K 10,000 at 60.00
14.8%
17 Dec 2020
CROOKE STANLEY T Exec Chairman of the Board · indirect
Sold, plan not stated
$71.05K 1,407 at 50.50
89.0%
Sold half or more
15 Dec 2020
CROOKE STANLEY T Exec Chairman of the Board · indirect
Sold, plan not stated
$1.94M 39,000 at 49.78
6.1%
7 Dec 2020
CROOKE STANLEY T Exec Chairman of the Board · indirect
Sold, plan not stated 2×
$568.35K 11,000 at 51.67
1.7%
4 Dec 2020
Monia Brett P Chief Executive Officer
Sold, plan not stated
$1.22M 23,840 at 51.04
45.2%
4 Dec 2020
BENNETT C FRANK Chief Scientific Officer
Sold, plan not stated
$405.61K 7,947 at 51.04
19.7%
2 Dec 2020
Monia Brett P Chief Executive Officer
Sold, plan not stated
$1.09M 21,160 at 51.32
42.3%
2 Dec 2020
BENNETT C FRANK Chief Scientific Officer
Sold, plan not stated
$361.96K 7,053 at 51.32
17.8%
25 Nov 2020
HOUGEN ELIZABETH L EVP, Finance & CFO
Sold, plan not stated
$1.09M 21,680 at 50.05
40.0%
25 Nov 2020
CROOKE STANLEY T Exec Chairman of the Board
Sold, plan not stated
$650.15K 12,990 at 50.05
86.5%
Sold half or more
25 Nov 2020
Geary Richard S EVP, Development
Sold, plan not stated
$596.60K 11,920 at 50.05
28.1%
25 Nov 2020
PARSHALL B LYNNE Director
Sold, plan not stated
$179.68K 3,590 at 50.05
5.1%
24 Nov 2020
HOUGEN ELIZABETH L EVP, Finance & CFO
Sold, plan not stated
$219.59K 4,320 at 50.83
11.7%
24 Nov 2020
CROOKE STANLEY T Exec Chairman of the Board
Sold, plan not stated
$131.65K 2,590 at 50.83
56.2%
Sold half or more
Showing 1–50 of 238. Page 1 of 5 Older →